Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study
- Conditions
- Arthritis
- Interventions
- Device: HRA
- First Posted Date
- 2015-02-24
- Last Posted Date
- 2015-02-24
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 59
- Registration Number
- NCT02369497
- Locations
- 🇺🇸
Bay Pines VA Healthcare System, Bay Pines, Florida, United States
Global Sinus Surgery Registry
- Conditions
- Recurrent Acute RhinosinusitisChronic Rhinosinusitis
- First Posted Date
- 2015-01-28
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 252
- Registration Number
- NCT02347943
Duragen® Secure Post Marketing Clinical Follow-up (PMCF)
- Conditions
- SurgeryDura Mater Nick Cut or Tear
- First Posted Date
- 2014-08-25
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT02225080
- Locations
- 🇫🇷
Hopital Lariboisière, Paris, France
🇩🇪die Charité - Universitätsmedizin Berlin, Berlin, Germany
🇬🇧National Hospital for Neurology and Neurosurgery, London, United Kingdom
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
- Conditions
- Diabetic Foot Ulcers
- Interventions
- Other: Standard of Care, Diabetic Foot UlcersOther: AMNIOEXCEL
- First Posted Date
- 2014-08-05
- Last Posted Date
- 2017-12-02
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 29
- Registration Number
- NCT02209051
- Locations
- 🇺🇸
Center for Clinical Research, Inc., Castro Valley, California, United States
🇺🇸Beth Israel Deaconess Hospital - Plymouth, Plymouth, Massachusetts, United States
🇺🇸Barry University Clinical Research, North Miami Beach, Florida, United States
Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion
- Conditions
- Otitis Media
- Interventions
- Device: Acclarent Tympanostomy Tube Delivery System (TTDS).
- First Posted Date
- 2014-05-29
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 29
- Registration Number
- NCT02150044
Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter
- Conditions
- Eustachian Tube Dysfunction
- Interventions
- Device: Acclarent Eustachian Tube Balloon Catheter (ETBC)
- First Posted Date
- 2014-03-14
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 323
- Registration Number
- NCT02087150
- Locations
- 🇺🇸
Piedmont Ear, Nose & Throat &Related Allergy, Atlanta, Georgia, United States
🇺🇸Florida Ear & Sinus Center, Sarasota, Florida, United States
🇺🇸Our Lady of the Lake Hospital, Baton Rouge, Louisiana, United States
ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study
- Conditions
- Pelvic Organ Prolapse
- Interventions
- Procedure: native tissue repairDevice: MatriStem Pelvic Floor Matrix
- First Posted Date
- 2013-12-27
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 161
- Registration Number
- NCT02021279
- Locations
- 🇺🇸
Garden State Urology, Whippany, New Jersey, United States
🇺🇸Princeton Urogynecology, Princeton, New Jersey, United States
🇺🇸Cleveland Clinic FLorida, Weston, Florida, United States
SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy
- Conditions
- Breast Cancer
- Interventions
- Other: No InterventionDevice: SurgiMend® PRS
- First Posted Date
- 2013-10-10
- Last Posted Date
- 2017-01-10
- Lead Sponsor
- Integra LifeSciences Corporation
- Registration Number
- NCT01959867
Retrospective Study Evaluating Outcomes for Integra® Skin Sheet Products in Lower Extremity Complex Wounds
- Conditions
- Complex Lower Extremity Soft Tissue Reconstruction
- First Posted Date
- 2013-09-20
- Last Posted Date
- 2016-12-02
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 320
- Registration Number
- NCT01947387
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine Division of Plastic Surgery, Chicago, Illinois, United States
🇺🇸Georgetown University Hospital Wound Healing Center, Washington, District of Columbia, United States
🇺🇸Brigham and Women's Hospital, Inc, Boston, Massachusetts, United States
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
- Conditions
- Foot Ulcer, Diabetic
- Interventions
- Device: MatriStemDevice: Cellular Dermal Replacement Tissue
- First Posted Date
- 2013-05-21
- Last Posted Date
- 2021-04-15
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 56
- Registration Number
- NCT01858545
- Locations
- 🇺🇸
Denver VA Medical Center, Denver, Colorado, United States
🇺🇸Professional Health Care of Pinellas, Saint Petersburg, Florida, United States
🇺🇸Center for Clinical Research Inc., Castro Valley, California, United States